Project Overview The primary objective of Sirtex Medical is to research, develop and commercialise effective treatments for liver cancer using novel small particle technology.The new SIR-Spheres branding needed to convey the personality of the product
as well as communicate the product key messages, such as proven, well tolerated, radiotheraphy, coverage.
The new identity has been used across all marketing collateral, including sales aids, adverts and conference stands.
REGISTERED OFFICE: 2 Heap Bridge, Bury, Lancashire BL9 7HR
REGISTERED IN ENGLAND & WALES No 02847659